873 H-NOX domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 7 | 10.2 | 0.69× | q = 0.26 | |
| Nucleosides, nucleotides, and analogues | 0 | 5.7 | 0 | q = 4.9e-3 | |
| Phenylpropanoids and polyketides | 2 | 0.4 | 4.64× | not tested | |
| Lipids and lipid-like molecules | 9 | 2.3 | 3.90× | not tested | |
| Benzenoids | 4 | 1.5 | 2.64× | not tested | |
| Organosulfur compounds | 1 | 0.4 | 2.35× | not tested | |
| Organic nitrogen compounds | 1 | 0.7 | 1.51× | not tested | |
| Homogeneous non-metal compounds | 6 | 4.5 | 1.35× | not tested | |
| Organoheterocyclic compounds | 3 | 3.2 | 0.94× | not tested | |
| Organic acids and derivatives | 1 | 3.2 | 0.31× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 94 |
| DB03796 | PLM | Palmitic Acid | 40 |
| DB09140 | OXY | Oxygen | 20 |
| DB02175 | MLA | Malonic acid | 10 |
| DB11588 | CMO | Carbon monoxide | 10 |
| DB03255 | IPH | Phenol | 9 |
| DB16126 | Z90 | Cinaciguat | 5 |
| DB08231 | MYR | Myristic acid | 3 |
| DB08342 | — | — | 3 |
| DB08931 | GZO | Riociguat | 3 |
| DB01688 | PCR | P-Cresol | 2 |
| DB01957 | 3CH | 3-Chlorophenol | 2 |
| DB02232 | CAQ | 1,2-Dihydroxybenzene | 2 |
| DB02671 | 1MZ | 1-Methylimidazole | 2 |
| DB04052 | 2MP | 3,4-Xylenol | 2 |
| DB04417 | NPO | P-Nitrophenol | 2 |
| DB16700 | XZ7 | Runcaciguat | 2 |
| DB00435 | — | — | 1 |
| DB01020 | — | — | 1 |
| DB09241 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 98 |
| ZNmetal | ZINC ION | 44 |
| PLM | PALMITIC ACID | 37 |
| OXY | OXYGEN MOLECULE | 20 |
| CL | CHLORIDE ION | 14 |
| CMO | CARBON MONOXIDE | 10 |
| IPH | PHENOL | 9 |
| MLA | MALONIC ACID | 9 |
| NO | NITRIC OXIDE | 8 |
| XE | XENON | 8 |
| NAmetal | SODIUM ION | 7 |
| MNH | MANGANESE PROTOPORPHYRIN IX | 6 |
| Z90 | 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]amino}methyl)benzoic acid | 5 |
| 1DX | 4-({(4-carboxybutyl)[2-(5-fluoro-2-{[4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]amino}methyl)benzoic acid | 4 |
| MYR | MYRISTIC ACID | 3 |
| 1MF | 4-{[(4-carboxybutyl)(2-{2-[(4'-phenoxybiphenyl-4-yl)methoxy]phenyl}ethyl)amino]methyl}benzoic acid | 2 |
| 1MZ | 1-METHYLIMIDAZOLE | 2 |
| 2MP | 3,4-DIMETHYLPHENOL | 2 |
| 3CH | 3-CHLOROPHENOL | 2 |
| 5JC | 2,4-dichlorophenol | 2 |